


Ask a doctor about a prescription for VIAFLO GLUCOSA 5% & SODIUM CHLORIDE 0.9% SOLUTION FOR INFUSION
PACKAGE LEAFLET: INFORMATION FOR THE USER
Viaflo Glucose 5% and Sodium Chloride 0.9% Solution for Infusion
Active substance: glucose, sodium chloride
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
This medicine is called “Viaflo Glucose 5% and Sodium Chloride 0.9% Solution for Infusion”, but will be referred to as “Viaflo Glucose 5% and Sodium Chloride 0.9%” throughout this leaflet.
Contents of the pack
Glucose is one of the body's sources of energy. This solution provides 200 kilocalories per liter. Sodium and chloride are chemical substances found in the blood.
Viaflo Glucose 5% and Sodium Chloride 0.9% is used:
Viaflo Glucose 5% and Sodium Chloride 0.9% will not be given to you in the following cases:
Warnings and precautions
Tell your doctor if you have or have had any of the following clinical situations:
This may increase the risk of low sodium levels in the blood and can cause headache, nausea, seizures, lethargy, coma, brain inflammation, and death. Brain inflammation increases the risk of death and brain damage. People at higher risk of brain inflammation are:
Conditions associated with sodium retention, fluid overload, and edema, such as:
Infusion may cause:
When you receive this infusion, your doctor may take blood and urine samples to monitor:
Since Viaflo Glucose 5% and Sodium Chloride 0.9% contains sugar (glucose), it may increase blood sugar levels (hyperglycemia). If this occurs, your doctor may:
This is particularly important:
Your doctor should consider whether you are receiving parenteral nutrition (nutrition administered by infusion into a vein). During prolonged treatment with Viaflo Glucose 5% and Sodium Chloride 0.9%, you may need to receive additional nutrition. Your doctor should also monitor your blood potassium levels to avoid abnormally low levels (hypokalemia).
Children
Special care should be taken when administering this solution to children, infants, and newborns (especially premature babies and those with low birth weight) as they may not have a good ability to handle the chemical substances in the solution.
Newborns - especially those born prematurely and with low birth weight - are at higher risk of developing low or high blood glucose levels (hypo or hyperglycemia) and therefore need careful monitoring during treatment with intravenous glucose solutions to ensure appropriate blood sugar control and avoid potential long-term adverse effects. Low blood sugar levels in newborns can cause prolonged seizures, coma, and brain damage. High blood sugar levels can cause brain hemorrhages, bacterial or fungal infections, eye damage (retinopathy of prematurity), intestinal infections (necrotizing enterocolitis), lung problems (bronchopulmonary dysplasia), prolonged hospital stay, and death.
Children are at higher risk of having low sodium levels in the blood (hyponatremia). Hyponatremia can cause headache, nausea, seizures, lethargy, coma, brain inflammation (cerebral edema), and death. Acute hyponatremic encephalopathy is a serious complication, especially in children. Your doctor is aware of all this and will carefully monitor the amount of chemical substances, such as sodium and chloride, in your child's blood (plasma electrolytes)
Other medicines and Viaflo Glucose 5% and Sodium Chloride 0.9%
Tell your doctor if you are taking, have recently taken, or might take any other medicines.
It is particularly important that you tell your doctor if you are taking:
These medicines can cause the body to retain sodium and water, leading to:
Some medicines affect the vasopressin hormone. These may include:
Other medicines that may affect or be affected by Viaflo Glucose 5% and Sodium Chloride 0.9%:
Viaflo Glucose 5% and Sodium Chloride 0.9% should not be administered through the same needle used for a blood transfusion, as it may damage red blood cells or cause them to clump.
Using Viaflo Glucose 5% and Sodium Chloride 0.9% with food and drinks
Ask your doctor what you can eat or drink.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or nurse before using this medicine.
Viaflo Glucose 5% and Sodium Chloride 0.9% can be administered during breastfeeding.
If another medicine is added to the infusion solution during pregnancy or breastfeeding, you should:
Driving and using machines
Viaflo Glucose 5% and Sodium Chloride 0.9% does not affect your ability to drive or use machines.
Viaflo Glucose 5% and Sodium Chloride 0.9% will be administered to you by a doctor or nurse. Your doctor will decide how much you need and when it should be administered. This will depend on your age, weight, physical condition, and the reason for treatment. The amount you receive may also be influenced by other treatments you are receiving.
DO NOT receive Viaflo Glucose 5% and Sodium Chloride 0.9% if there are particles floating in the solution or if the container is damaged in any way.
Generally, Viaflo Glucose 5% and Sodium Chloride 0.9% will be administered to you through a plastic tube attached to a needle inserted into a vein. However, your doctor may administer the medicine in another way.
Any unused solution should be discarded. DO NOT receive Viaflo Glucose 5% and Sodium Chloride 0.9% from a partially used bag.
Before and during infusion, your doctor will monitor:
If you are given too much Viaflo Glucose 5% and Sodium Chloride 0.9%
If you receive too much Viaflo Glucose 5% and Sodium Chloride 0.9% solution or if the administration is too rapid, you may experience the following symptoms:
If you develop any of these symptoms, inform your doctor immediately. The infusion will be stopped and you will receive treatment based on the symptoms.
If a medicine has been added to Viaflo Glucose 5% and Sodium Chloride 0.9% before excessive administration, that medicine may also cause symptoms. You should read the list of possible symptoms in the package leaflet of the added medicine.
In case of overdose or accidental ingestion, consult the Toxicology Information Service. Phone: 91 562 04 20.
Stopping the infusion of Viaflo Glucose 5% and Sodium Chloride 0.9%
Your doctor will decide when you should stop receiving this infusion.
If you have any further questions about the use of this product, ask your doctor or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects may be related to Viaflo Glucose 5% and Sodium Chloride 0.9%. These include:
Side effects may be due to the administration technique. This includes:
If a medicine has been added to the infusion solution, it may also cause side effects. These side effects will depend on the added medicine. You should read the list of possible symptoms in the package leaflet of the added medicine.
Reporting of side effects:
If you experience any side effects, talk to your doctor or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Viaflo Glucose 5% and Sodium Chloride 0.9% does not require special storage conditions.
Viaflo Glucose 5% and Sodium Chloride 0.9% should NOT be administered after the expiry date stated on the bag after EXP. The expiry date is the last day of the month indicated.
You should not receive Viaflo Glucose 5% and Sodium Chloride 0.9% if there are particles floating in the solution or if the container is damaged in any way.
Composition of Viaflo Glucose 5% and Sodium Chloride 0.9%
The active ingredients are
The other component is water for injectable preparations.
Appearance of the Product and Container Contents
Viaflo Glucose 5% and Sodium Chloride 0.9% is a clear, particle-free solution. It is presented in polyolefin/polyamide (Viaflo) plastic bags. Each bag is packaged in a sealed protective plastic overbag.
The bag sizes are:
The bags are supplied in boxes, each containing the following quantities:
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Holder
Baxter S.L.
Pouet de Camilo, 2
46394, Ribarroja del Turia (Valencia)
Manufacturer:
Bieffe Medital S.A.
Ctra de Biescas, Senegüé
22666 Sabiñanigo (Huesca)
Spain
Baxter SA
Boulevard René Branquart, 80
7860 Lessines
Belgium
Date of Last Revision of thisProspectus: October 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
This information is intended only for healthcare professionals
Handling and Preparation
Use only if the solution is clear, free of visible particles, and if the container is not damaged. Administer immediately after connecting the infusion equipment.
Do not remove the bag from its overbag until it is ready for use.
The inner bag maintains the product's sterility.
Do not connect plastic containers in series. This type of connection can produce gas embolisms due to residual air drawn from the primary container before the administration of the liquid contained in the secondary container is complete.
The pressurization of intravenous solutions in flexible plastic containers to increase flow rates can lead to a gas embolism if the residual air in the container is not fully evacuated before administration.
The use of an intravenous administration set with a ventilation filter in the open position could cause a gas embolism. This type of intravenous administration set with the ventilation filter in the open position should not be used with flexible plastic containers.
The solution must be administered with sterile equipment using an aseptic technique. The equipment must be primed with the solution to prevent air from entering the system.
Medications can be introduced before or during infusion through the resealable medication port.
When adding medications, verify isotonicity before parenteral administration. A complete and careful aseptic mixture of any added medication is necessary. Solutions containing added medications should be used immediately and not stored.
Pediatric Population
In order to avoid a potentially fatal overdose during the infusion of intravenous solutions to newborns, special attention should be paid to the administration method. When using a syringe pump to administer liquids or medications intravenously to newborns, a solution bag should not be left connected to the syringe.
When using an infusion pump, all clamps on the intravenous administration set must be closed before removing the administration set from the pump or disconnecting the pump. This is required regardless of whether the administration set has an anti-free flow device.
The intravenous infusion device and administration set should be monitored frequently.
Discard after single use
Discard any remaining portion.
Do not reconnect partially used bags.
1- To Open
a- Remove the Viaflo bag from the protective overbag immediately before use.
b- Check for the absence of small leaks by squeezing the inner bag firmly. If leaks are detected, discard the solution, as it may not be sterile.
c- Check the transparency of the solution and the absence of foreign particles. Discard the solution if it is not transparent or contains foreign particles.
2- Preparation for Administration
Use sterile material for preparation and administration.
a- Hang the container by the hanger
b- Remove the plastic protector from the outlet port at the bottom of the container. - Hold the small wing of the outlet port neck with one hand. - Hold the large wing of the closure cap with the other hand and turn. - The cap will come off.
c- Use an aseptic technique to prepare the infusion
d- Connect the administration set. Consult the instructions accompanying the set for connection, priming, and administration of the solution.
3- Techniques for Injecting Added Medication
Warning: Added medications may be incompatible (see section 5 "Incompatibilities of Added Medications" below).
To add medication before administration.
a- Disinfect the medication port
b- Using a syringe with a 19 G (1.10 mm) to 22 G (0.70 mm) needle, puncture the resealable medication port and inject.
c- Carefully mix the medication and solution. For high-density medications, such as potassium chloride, gently move the tubes while they are in a vertical position and mix.
Precaution: do not store bags with added medication.
To add medication during administration
a- Close the clamp on the administration set
b- Disinfect the medication port
c- Using a syringe with a 19 G (1.10 mm) to 22 G (0.70 mm) needle, puncture the resealable medication port and inject.
d- Remove the container from the IV stand and/or turn it to put it in a vertical position.
e- Empty both tubes by gently tapping them while the container is in a vertical position
f- Carefully mix the solution and medication
g- Put the container back in the use position, reopen the clamp, and continue administration
Before use, the physical and chemical stability of any added medication must be established at the pH of the Viaflo Glucose 5% and Sodium Chloride 0.9% solution in the Viaflo container.
From a microbiological point of view, the diluted product must be used immediately. If not used immediately, the storage conditions and period before use are the responsibility of the user and will normally not exceed 24 hours at 2-8°C, unless reconstitution has been carried out under controlled and validated aseptic conditions.
5- Incompatibilities of Added Medications
As with all parenteral solutions, the compatibility of added medications with the solution in the Viaflo bag must be verified before addition.
It is the physician's responsibility to assess the incompatibility of the added medication with Viaflo Glucose 5% and Sodium Chloride 0.9% by examining any change in color and/or precipitate, insoluble complexes, or appearance of crystals. The prospectus of the medication to be added should be consulted.
Before adding a medication, verify that it is soluble and stable in water at the pH of the Viaflo Glucose 5% and Sodium Chloride 0.9% solution (pH 3.5 to 6.5).
When adding compatible medication to Viaflo Glucose 5% and Sodium Chloride 0.9%, the solution must be used immediately.
As a guide, the following medications are incompatible with Viaflo Glucose 5% and Sodium Chloride 0.9% (non-exhaustive list):
Due to the presence of glucose, Viaflo Glucose 5% and Sodium Chloride 0.9% should not be administered through the same infusion equipment as whole blood, as hemolysis and agglutination may occur.
Medications known to be incompatible should not be used.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for VIAFLO GLUCOSA 5% & SODIUM CHLORIDE 0.9% SOLUTION FOR INFUSION – subject to medical assessment and local rules.